Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03476174
Title Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ralph Hauke
Indications

melanoma

Therapies

Aldesleukin + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.